| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Nov―21 |
Associations Between APOE Polymorphisms, Neurological Symptoms, and Cognitive Assessments in Long COVID Patients: An Analysis of SNPs rs7412 and rs429358 |
Isadora de Almeida Gomes, Pedro Braga-Neto, Thiago Loreto Matos, Emerson Lucena da Silva, Lais Lacerda Brasil de Oliveira, Luina Benevides Lima, et al. (+11) José Wagner Leonel Tavares-Júnior, Alissa Elen Formiga Moura, Marcello Holanda de Andrade, Thaís de Maria Frota Vasconcelos, Reinaldo Barreto Oriá, Danilo Nunes Oliveira, Manoel Alves Sobreira-Neto, Pedro Filho Noronha Souza, Maria Elisabete Amaral de Moraes, Felipe Pantoja Mesquita, Raquel Carvalho Montenegro |
| 2 |
[GO] |
2024―Oct―21 |
Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization |
Carla Andretta Moreira Neves, Gilson P. Dorneles, Paula C. Teixeira, Paulo C. Santana Filho, Alessandra Peres, Carina Rodrigues Boeck, et al. (+3) Liane N. Rotta, Claudia E. Thompson, Pedro R. T. Romão |
| 3 |
[GO] |
2024―Sep―14 |
A Gene Cluster of Mitochondrial Complexes Contributes to the Cognitive Decline of COVID-19 Infection |
Wen-tao Xu, Xiao-bin An, Mei-jie Chen, Jing Ma, Xu-qiao Wang, Ji-nan Yang, et al. (+7) Qin Wang, Dong-yang Wang, Yan Wu, Lu Zeng, Yang Qu, Bowen Zhao, Jing Ai |
| 4 |
[GO] |
2024―Aug―12 |
A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC) |
Apoorva Saxena, Josef Mautner |
| 5 |
[GO] |
2024―Jul―04 |
Potential Mechanisms Underlying COVID-19-Mediated Central and Peripheral Demyelination: Roles of the RAAS and ADAM-17 |
Kellysson Bruno Oliveira, Fernanda Maria Araujo de Souza, Letícia Barros Maurício de Sá, Amanda Larissa Dias Pacheco, Mariana Reis Prado, Célio Fernando de Sousa Rodrigues, et al. (+6) Ênio José Bassi, Igor Santana-Melo, Abelardo Silva-Júnior, Robinson Sabino-Silva, Ashok K. Shetty, Olagide Wagner de Castro |
| 6 |
[GO] |
2024―May―03 |
Alterations in Circadian Rhythms, Sleep, and Physical Activity in COVID-19: Mechanisms, Interventions, and Lessons for the Future |
Sandip Das, Rajni Khan, Srishti Banerjee, Shashikant Ray, Sandipan Ray |
| 7 |
[GO] |
2024―Mar―20 |
High Frequency of Autoantibodies in COVID-19 Patients with Central Nervous System Complications: a Multicenter Observational Study |
Jingfang Lin, Dong Zheng, Decai Tian, Pei Zheng, Hongya Zhang, Chuo Li, et al. (+3) Chunliang Lei, Fudong Shi, Honghao Wang |
| 8 |
[GO] |
2024―Feb―01 |
Association Between COVID-19 and Neurological Diseases: Evidence from Large-Scale Mendelian Randomization Analysis and Single-Cell RNA Sequencing Analysis |
Lin Huang, Yongheng Wang, Yijie He, Dongyu Huang, Tong Wen, Zhijie Han |
| 9 |
[GO] |
2023―Dec―20 |
COVID-19, Anxiety, and Body Mass Index Increase Leptin Levels: a Cross-sectional Multicentric Study |
Gislaine Z. Réus, Kelen C. C. Recco, Karynne M. S. H. Machado, Ritele H. Silva, Camila O. Arent, Graziela Amboni, et al. (+13) Flávia S. Niero, Lucas C. Pedro, Laura A. Borba, Margarete D. Bagatini, Gabriela G. de Oliveira, Alana Patrícia da Silva, Maiqueli Eduarda D. Mingoti, Zuleide Maria Ignácio, Fernanda F. Gava, Fabricia Petronilho, João Quevedo, Luciane B. Ceretta, Taiane de Azevedo Cardoso |
| 10 |
[GO] |
2023―Nov―24 |
High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19 |
Andreza Lemos Salvio, Renan Amphilophio Fernandes, Helena França Alcaraz Ferreira, Larissa Araujo Duarte, Elisa Gouvea Gutman, Jessica Vasques Raposo-Vedovi, et al. (+12) Carlos Henrique Ferreira Ramos Filho, Wagner Luis da Costa Nunes Pimentel Coelho, Giselle Fazzioni Passos, Maria Emília Cosenza Andraus, João Paulo da Costa Gonçalves, Marta Guimarães Cavalcanti, Marisa Pimentel Amaro, Rafael Kader, Roberto de Andrade Medronho, Cláudia Pinto Figueiredo, Luciane Almeida Amado-Leon, Soniza Vieira Alves-Leon |
| 11 |
[GO] |
2023―Nov―14 |
Does COVID-19 Trigger the Risk for the Development of Parkinson’s Disease? Therapeutic Potential of Vitamin C |
Rhea Subba, Amal Chandra Mondal |
| 12 |
[GO] |
2023―Oct―28 |
SARS-CoV-2 Spike Protein S1 Domain Accelerates α-Synuclein Phosphorylation and Aggregation in Cellular Models of Synucleinopathy |
Jiannan Wang, Lijun Dai, Min Deng, Tingting Xiao, Zhaohui Zhang, Zhentao Zhang |
| 13 |
[GO] |
2023―Oct―24 |
Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19 |
Mahsa Aghajani Mir |
| 14 |
[GO] |
2023―Oct―11 |
Comprehensive Risk Assessment of Infection Induced by SARS-CoV-2 |
KB. Megha, S. Reshma, S. Amir, MJ. Ajai Krishnan, A. Shimona, Rao Alka, PV. Mohanan |
| 15 |
[GO] |
2023―Sep―20 |
What Is the Impact of the Novel Coronavirus and the Vaccination on Guillain-Barre Syndrome? |
Yinuo Chen, Kezheng Li, Wenjing Lv, Jiali Xie, Yuqin Qian, Can Cui, Binbin Deng |
| 16 |
[GO] |
2023―Aug―29 |
Regulation of Inflammation by IRAK-M Pathway Can Be Associated with nAchRalpha7 Activation and COVID-19 |
Alessanda S. Rieder, Angela T. S. Wyse |
| 17 |
[GO] |
2023―Jul―21 |
Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells |
Irene Tsilioni, Theoharis C. Theoharides |
| 18 |
[GO] |
2022―Jul―20 |
A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor |
Juan Facundo Chrestia, Ana Sofia Oliveira, Adrian J. Mulholland, Timothy Gallagher, Isabel Bermúdez, Cecilia Bouzat |
| 19 |
[GO] |
2022―Jul―13 |
Long-Term Sequelae of COVID-19 in Experimental Mice |
Michael J. Paidas, Daniela S. Cosio, Saad Ali, Norma Sue Kenyon, Arumugam R. Jayakumar |
| 20 |
[GO] |
2022―Jan―13 |
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? |
Theoharis C. Theoharides |
| 21 |
[GO] |
2021―Oct―28 |
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia |
Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Oyinkansola D. Adegbola, Alaa A. Al-Hindawi |
| 22 |
[GO] |
2021―Aug―27 |
NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection |
Marina Saresella, Daria Trabattoni, Ivana Marventano, Federica Piancone, Francesca La Rosa, Antonio Caronni, et al. (+8) Agata Lax, Luca Bianchi, Paolo Banfi, Jorge Navarro, Elisabetta Bolognesi, Milena Zanzottera, Franca Rosa Guerini, Mario Clerici |
| 23 |
[GO] |
2021―Jul―27 |
Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection |
Shiek S. S. J. Ahmed, Prabu Paramasivam, Manjunath Kamath, Ashutosh Sharma, Sophie Rome, Ram Murugesan |
| 24 |
[GO] |
2021―Jul―11 |
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection |
Júlia Leão Batista Simões, Julia Beatrice de Araújo, Margarete Dulce Bagatini |
| 25 |
[GO] |
2021―Jun―26 |
COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease |
Che Mohd Nasril Che Mohd Nassir, Sabarisah Hashim, Kah Keng Wong, Sanihah Abdul Halim, Nur Suhaila Idris, Nanthini Jayabalan, et al. (+2) Dazhi Guo, Muzaimi Mustapha |
| 26 |
[GO] |
2021―Jun―24 |
Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic |
Saikat Dewanjee, Jayalakshmi Vallamkondu, Rajkumar Singh Kalra, Nagaprasad Puvvada, Ramesh Kandimalla, P. Hemachandra Reddy |
| 27 |
[GO] |
2021―Jun―10 |
Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction |
Ravinder K. Kaundal, Anil K. Kalvala, Ashutosh Kumar |
| 28 |
[GO] |
2021―Jun―05 |
A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development |
Medha Karnik, Narasimha M. Beeraka, Chinnappa A. Uthaiah, Suma M. Nataraj, Anjali Devi S. Bettadapura, Gjumrakch Aliev, SubbaRao V. Madhunapantula |
| 29 |
[GO] |
2021―Jun―01 |
The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease |
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi |
| 30 |
[GO] |
2021―May―25 |
The Intersection of Parkinson’s Disease, Viral Infections, and COVID-19 |
Benjamin Rosen, Alberim Kurtishi, Gonzalo R. Vazquez-Jimenez, Simon Geir Møller |
| 31 |
[GO] |
2021―May―25 |
Characterization of Headache in COVID-19: a Retrospective Multicenter Study |
Rafael César dos Anjos de Paula, Thaís de Maria Frota Vasconcelos, Francisco Bruno Santana da Costa, Lara Albuquerque de Brito, Danielle Mesquita Torres, Alissa Elen Formiga Moura, et al. (+14) Danilo Nunes Oliveira, Guilherme Alves de Lima Henn, Pedro Gustavo Barros Rodrigues, Isabelle de Sousa Pereira, Ianna Lacerda Sampaio Braga, Felipe Araújo Rocha, Norberto Anízio Ferreira Frota, Fernanda Martins Maia Carvalho, Milena Sales Pitombeira, José Wagner Leonel Tavares-Junior, Raquel Carvalho Montenegro, Pedro Braga-Neto, Paulo Ribeiro Nóbrega, Manoel Alves Sobreira-Neto |
| 32 |
[GO] |
2021―Mar―25 |
Nervous System Involvement in COVID-19: a Review of the Current Knowledge |
Mahnaz Norouzi, Paniz Miar, Shaghayegh Norouzi, Parvaneh Nikpour |
| 33 |
[GO] |
2021―Mar―14 |
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19 |
Dipak Kumar, Sadaf Jahan, Andleeb Khan, Arif Jamal Siddiqui, Neeru Singh Redhu, Johra Khan, et al. (+3) Saeed Banwas, Bader Alshehri, Mohammed Alaidarous |
| 34 |
[GO] |
2021―Mar―08 |
Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19 |
Ranjana Bhandari, Garima Khanna, Dhriti Kaushik, Anurag Kuhad |
| 35 |
[GO] |
2021―Jan―27 |
Correction to: Pathophysiological Clues to how the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration |
Mahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi |
| 36 |
[GO] |
2021―Jan―14 |
SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism |
Mohan Kumar Muthu Karuppan, Dinesh Devadoss, Madhavan Nair, Hitendra S. Chand, Madepalli K. Lakshmana |
| 37 |
[GO] |
2021―Jan―08 |
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration |
Mahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi |
| 38 |
[GO] |
2021―Jan―06 |
Brain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19 |
Kartikay Prasad, Suliman Yousef AlOmar, Saeed Awad M. Alqahtani, Md. Zubbair Malik, Vijay Kumar |
| 39 |
[GO] |
2021―Jan―06 |
Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates |
Roberta Eduarda Grolli, Maiqueli Eduarda Dama Mingoti, Amanda Gollo Bertollo, Adriana Remião Luzardo, João Quevedo, Gislaine Zilli Réus, Zuleide Maria Ignácio |
| 40 |
[GO] |
2021―Jan―06 |
Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders |
Sharifa Hasana, Md. Farhad Hossain, Maroua Jalouli, Md. Tanvir Kabir, Md. Giash Uddin, Mir Imam Ibne Wahed, et al. (+5) Tapan Behl, May N. Bin-Jumah, Mohamed M. Abdel-Daim, Lotfi Aleya, Md. Sahab Uddin |
| 41 |
[GO] |
2020―Oct―19 |
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease |
Mohammad Azizur Rahman, Kamrul Islam, Saidur Rahman, Md Alamin |
| 42 |
[GO] |
2020―Oct―16 |
Neurological Involvements of SARS-CoV2 Infection |
Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Asma Gasmi Benahmed, Alain Menzel, Maryam Dadar, Geir Bjørklund |
| 43 |
[GO] |
2020―Sep―29 |
Multiple Neuroinvasive Pathways in COVID-19 |
Dmitri Bougakov, Kenneth Podell, Elkhonon Goldberg |
| 44 |
[GO] |
2020―Sep―26 |
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View |
Hamid Soltani Zangbar, Ali Gorji, Tahereh Ghadiri |
| 45 |
[GO] |
2020―Sep―25 |
Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection |
Iván Alquisiras-Burgos, Irlanda Peralta-Arrieta, Luis Antonio Alonso-Palomares, Ana Elvira Zacapala-Gómez, Eric Genaro Salmerón-Bárcenas, Penélope Aguilera |
| 46 |
[GO] |
2020―Sep―08 |
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications |
Wei-Yi Ong, Mei-Lin Go, De-Yun Wang, Irwin Kee-Mun Cheah, Barry Halliwell |
| 47 |
[GO] |
2020―Sep―01 |
Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms |
Soheil Mohammadi, Fatemeh Moosaie, Mohammad Hadi Aarabi |
| 48 |
[GO] |
2020―Aug―19 |
Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic |
Pooja Kaushik, Medha Kaushik, Sabiha Parveen, Heena Tabassum, Suhel Parvez |
| 49 |
[GO] |
2020―Aug―18 |
Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection |
Jasvinder Singh Bhatti, Gurjit Kaur Bhatti, Naina Khullar, Arubala P. Reddy, P. Hemachandra Reddy |
| 50 |
[GO] |
2020―Jul―15 |
Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics |
Ramesh Kandimalla, Albin John, Chandrika Abburi, Jayalakshmi Vallamkondu, P. Hemachandra Reddy |